Publications by authors named "Amy Sion"

Claim this Profile
I
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.
Katherine S Virgo, R Bryan Rumble, Ronald de Wit, David S Mendelson, Thomas J Smith, Amy M Sion

J Clin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Montelukast-Based Premedication Regimen for Recurrent Cetuximab Infusion-Related Reactions.
Amy M Sion, Lyndsey Milburn, John M Kaczmar

JCO Oncol Pract· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials.
Jessica H McElwee, Theodore S Gourdin, Jennifer Mikoll, Erin Weeda, Amy M Sion

J Oncol Pharm Pract· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of arthralgias in adult oncology patients receiving immune checkpoint inhibitors.
Jenessa Lee, Anastasia Graham, Amy Sion

J Oncol Pharm Pract· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Kasey Jackson, Cathy Letton, Andy Maldonado, Andrew Bodiford, Amy Sion

J Oncol Pharm Pract· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy.
Hammad Shafqat, Theodore Gourdin, Amy Sion

Semin Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.
John M Wrangle, Vamsidhar Velcheti, Manish R Patel, Elizabeth Garrett-Mayer, Elizabeth G Hill, Amy Sion

Lancet Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress and IGF-I differentially control cell fate through mammalian target of rapamycin (mTOR) and retinoblastoma protein (pRB).
Melissa Popowski, Heather A Ferguson, Amy M Sion, Erich Koller, Erik Knudsen

J Biol Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2D6 polymorphisms and the impact on tamoxifen therapy.
Jacob N Beverage, Tristan M Sissung, Amy M Sion, Romano Danesi, William D Figg

J Pharm Sci· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysyl oxidase (LOX) and hypoxia-induced metastases.
Amy M Sion, William D Figg

Cancer Biol Ther· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis